Bought
Maintained
Sold
Other funds holding PMD
UBS's PMD Position: Q3 2014 in Review
UBS increased its Psychemedics (PMD) stake by 967% in Q3 2014, buying an estimated $131K and bringing the position to 10,171 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #5542.
UBS first reported a position in PMD in Q2 2013 and has held it in 6 quarters since. 33 funds tracked by Wall St. Rank hold PMD as of Q3 2014.
- UBS held 10,171 shares of Psychemedics worth $144K as of Q3 2014.
- UBS bought 9,218 Psychemedics shares in Q3 2014, an estimated $131K.
- Psychemedics made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5542 holding.
- UBS first reported a position in Psychemedics in Q2 2013 and has held it in 6 quarters since.
- 33 funds tracked by Wall St. Rank held Psychemedics as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.